Back to Journals » Cancer Management and Research » Volume 11
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Long Noncoding RNA LINC00511 Promotes Cell Growth And Invasion In Triple-Negative Breast Cancer By Interacting With Snail [Retraction]
Liu R, Wang L, Gan T, Pan T, Huang J, Bai M. Long noncoding RNA LINC00511 promotes cell growth and invasion in triple-negative breast cancer by interacting with Snail. Cancer Manage Res. 2019;11:5691–5699.
The Editor-in-Chief and Publisher of Cancer Management and Research wish to retract the published article.
Following publication of the present article, the corresponding authors, Jianglong Huang and Mingjun Bai, submitted a new article to the journal OncoTargets and Therapy. During routine integrity checks it was found nearly all the text, results and figures of the new submission were identical to those of the previously published article. The only significant difference was the long noncoding RNA LINC00511 sequence, described in the published article, had been replaced with the long noncoding RNA LINC02474 sequence. Concerns were raised immediately to the Editor-in-Chief of Cancer Management and Research about the integrity of the published article.
As part of our investigation the authors were contacted but failed to provide a satisfactory explanation and were unable to provide the raw data for their study. It was also found there were unacceptable levels of similarity between the published article and several other articles reporting cancer studies involving long noncoding RNA sequences. The authors department at the Third Affiliated Hospital, Sun Yat-sen University was contacted and also shared our concerns regarding the validity of this study.
This retraction relates to this paper
© 2019 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms.php
and incorporate the Creative Commons Attribution
- Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.